Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|November 6, 2023
Salvage therapy for BCG failure with intravesical sequential gemcitabine and docetaxel in patients with recurrent NMIBCCharles-Antoine Garneau, Nathalie Marcotte, Louis Lacombe, et al.
IJID Regions|July 11, 2026
Scrotal filariasis: a case report and clinical considerationsClément Larose, Laura Bollaro, Alix Martin-Bertaux, et al.
JAMA Oncology|September 18, 2015
Intermittent vs Continuous Androgen Deprivation Therapy for Prostate Cancer: A Systematic Review and Meta-analysisSindy Magnan, Ryan Zarychanski, Laurie Pilote, et al.
European Urology Focus|July 30, 2017
Metabolic Imaging of Prostate Cancer Reveals Intrapatient Intermetastasis Response Heterogeneity to Systemic TherapyFannie Morin, Jean-Mathieu Beauregard, Michelle Bergeron, et al.
BMC Cancer|January 12, 2018
Effects of concentrated long-chain omega-3 polyunsaturated fatty acid supplementation before radical prostatectomy on prostate cancer proliferation, inflammation, and quality of life: study protocol for a phase IIb, randomized, double-blind, placebo-controlled trialMarie-Hélène Guertin, Karine Robitaille, Jean-François Pelletier, et al.
Research and Reports in Urology|June 4, 2014
IL-8 secretion in primary cultures of prostate cells is associated with prostate cancer aggressivenessBertrand Neveu, Xavier Moreel, Marie-Pier Deschênes-Rompré, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|November 7, 2017
Validation of the French-Canadian version of the Expanded Prostate Cancer Index Composite (EPIC) in a French-Canadian populationÉric Vigneault, Josée Savard, Marie-Hélène Savard, et al.
Diagnostic Pathology|June 14, 2015
Comparison of digital image analysis and visual scoring of KI-67 in prostate cancer prognosis after prostatectomyPatrice Desmeules, Hélène Hovington, Molière Nguilé-Makao, et al.
BMC Medical Genomics|June 27, 2021
Whether, when, how, and how much? General public's and cancer patients' views about the disclosure of genomic secondary findingsJude Emmanuel Cléophat, Michel Dorval, Zaki El Haffaf, et al.
The Prostate|August 4, 2018
Omega-3 fatty acids decrease prostate cancer progression associated with an anti-tumor immune response in eugonadal and castrated miceNikunj Gevariya, Marjorie Besançon, Karine Robitaille, et al.
Pageof 8